NM_000726.5(CACNB4):c.959C>T (p.Ala320Val) AND Epilepsy, idiopathic generalized, susceptibility to, 9
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Apr 16, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001839306.1
Allele description [Variation Report for NM_000726.5(CACNB4):c.959C>T (p.Ala320Val)]
NM_000726.5(CACNB4):c.959C>T (p.Ala320Val)
Condition(s)
-
malate dehydrogenase, partial [Escherichia sp. ESBL386B15_13_2A]
malate dehydrogenase, partial [Escherichia sp. ESBL386B15_13_2A]gi|672920718|gb|AIK21699.1|Protein
-
Nivolumab (Opdivo)
Nivolumab (Opdivo)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Dec 24, 2023